Missouri Has Expunged 15,000+ Cannabis Crimes Since Adult-Use Reforms

March 22, 2023 · Ganjapreneur

Following adult-use cannabis legalization in Missouri, the state has granted more than 15,000 expungements of nonviolent misdemeanor and felony cannabis crimes, KMOV reports. Under the state’s voter-approved adult-use cannabis law, possession of up to three ounces is legal for adults and all eligible misdemeanors for individuals who completed their sentences must be expunged automatically by June 8, while low-level felonies must be expunged by December 8.  

Charges that included selling cannabis to a minor, violence, or driving under the influence are not eligible for relief. Individuals currently incarcerated for cannabis convictions, including past misdemeanors and Class E and D felonies involving possession of under three pounds, can ask the court to vacate the sentence, which would lead to an immediate release and the expungement of the record.

Individuals on probation or parole will have their records automatically expunged and all prior Class A, B, C, or D felonies for possession over three pounds will be expunged automatically after the person completes their sentence. 

In order to complete the expungements required under the law, the Missouri Office of State Courts Administration has submitted to the legislature a supplemental budget request for this fiscal year, asking for about $2.5 million in additional funds to cover overtime for clerks and hire additional information technology professionals, according to a KCUR report. In the request, the agency said it would also need $2.2 million in personal services dollars “for the increased workload of the courts, utilizing temporary staff and overtime.”  

The Court Administration said it would incur costs for expungements, sentences automatically vacated within specified timeframes, and creation of a special index of expunged cases.  (Full Story)

In category:Legal
Tags:
Next Post

Judge tosses Arkansas marijuana dispensary applicant’s suit over scoring

A federal judge in Arkansas dismissed several claims by a medical marijuana dispensary applicant, including tortious interference and racial discrimination during the state’s license-evaluation process. According to Law360, U.S. District Judge James Moody Jr. ruled that tortious interference doesn’t apply to the…
Read
Previous Post

Brazil to rule whether businesses can plant cannabis, potentially opening passage to legal cultivation

A Brazilian appeals court has agreed to rule on whether companies and farmers can plant cannabis in the country, which could open the door to legal cultivation for medicinal and industrial purposes after legislative efforts stalled in recent years. The decision by…
Read
Random Post

RI House OKs bill to legalize ‘magic mushrooms’ statewide

Rhode Island is one step closer to decriminalizing so-called “magic mushrooms” statewide. The House approved legislation Monday that would allow Rhode Islanders to possess up to one ounce of psilocybin or grow magic mushrooms at home for personal use. It would also,…
Read
Random Post

New York’s Long Island opts out of marijuana retail, limiting options for store operators

When New York regulators announced plans to double recreational marijuana retail licenses to 300 for social equity applicants, local cannabis operators and other industry advocates applauded the news. But behind the scenes, concerns were mounting over the challenge of finding affordable cannabis…
Read
Random Post

What Ever Happened to the Elephant That was Given 300mg of LSD as Part of a Science Experiment?

Tusko the elephant was recently honored in a tribute by Guinness World Records, the official repository of amazing human feats and natural world extremes. Tusko, a male Indian elephant at the Oklahoma City Zoo, died as a result of a…
Read
Random Post

Engineering Psychedelics: $22M Pool For Clinical Trials Of Compounds Targeting CNS Disorders

NYC and Cambridge-based Empyrean Neuroscience Inc. is a new genetic engineering company developing neuroactive compounds for neuropsychiatric and neurological disorders launching with a $22 million Series A financing. The company’s CEO is long-time biotech executive Dr. Usman “Oz” Azam, joined by Dr. Fred Grossman as chief medical officer.…
Read